Tate & Lyle to enter into new joint development agreement with Genomatica to produce Bio-BDO
DECATUR, IL – Tate Lyle announced today it has entered into a joint development agreement with San Diego based Genomatica for the demonstration-scale production of Genomatica’s Bio-BDO (1,4-butanediol).
Under the agreement, Tate Lyle will dedicate a demonstration-scale production facility in Decatur, Illinois, for exclusive use by Genomatica for the scale-up of the Bio-BDO process. This demonstration facility is expected to create 25 local jobs including research, engineering, and frontline technician positions. Engineering of the demonstration facility is already underway and fermentations are expected to begin in the second quarter of this year with full-integrated plant operations in the third quarter.
BDO, an intermediate chemical with a $4 billion market worldwide, is used to make spandex, automotive plastics, running shoes, insulation, and other derivatives. Genomatica’s process produces the same BDO product that is currently made from a variety of petroleum-derived sources, but uses 100% renewable ingredients.
“We are excited to be working with Genomatica to create the first commercialization of its Bio-BDO product,” said Matt Wineinger, President, Bulk Ingredients, Tate Lyle. “The combination of Genomatica’s technology and successful BDO commercial experience with Tate Lyle’s fermentation expertise and operational capabilities are an excellent fit”.
Tate Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.
Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches, sweeteners and fibres), no calorie sweeteners (including SPLENDA® Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.
Tate Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2012, Tate Lyle sales totalled £3.1 billion. http://www.tateandlyle.com. SPLENDA® is a trademark of McNeil Nutritionals, LLC
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
